Dr. Richard Paul Junghans MD
Oncologist | Medical Oncology
800 WASHINGTON ST BOSTON MA, 02111About
Dr. Richard Junghans is an oncologist practicing in Providence, RI. Dr. Junghans specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Junghans manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Anti-Gal antibodies-where's the beef?
- Cruel antibody fictions! Cellular antigen enumeration by 'saturation' binding.
- Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
- Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor.
- The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile.
- Ultracentrifugal analysis of molecular mass of glycoproteins of unknown or ill-defined carbohydrate composition.
- Interleukin 2 maintains biologic stability and sterility over prolonged time.
- Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.
- Anti-CD30 antibody-based therapy.
- Direct immunoprecipitation of antigen with phage displaying immunoglobulin fragment.
- Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death.
- Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.
- Biventricular cardiac thrombosis during interleukin-2 infusion.
- Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.
- Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.
Dr. Richard Paul Junghans MD's Practice location
Dr. Richard Paul Junghans MD's reviews
Write ReviewPatient Experience with Dr. Junghans
Recommended Articles
- Woman Hits Hole-in-One After Fifth Breast Cancer Operation
Breast cancer patients often find rehabilitation and recovery to be a long, arduous process. It can be hard to get back into a normal routine after going through the countless chemotherapy sessions and surgeries that often come with cancer rehabilitation. One survivor from Old Hickory, Tennessee set...
- Comparative Value of PARP Inhibitors is Lacking, According to ICER Report
The Institute for Clinical and Economic Review, also known as ICER, is a non-profit organization that analyzes the value of new medical tests, treatments, and drugs approved by the U.S. Food and Drug Administration (FDA). The goal of ICER is to use the value of these innovations and develop reports...
- What Is Bone Marrow? - Diseases, Symptoms, and Transplant
What Is Bone Marrow?Bone Marrow is the flexible tissue present in the interior of the bones. Constituting only about 4% of the body mass in the human body, Bone marrow is responsible for 500 billion blood cells every day. It is also a key component of the lymphatic system as it produces lymphocytes...
- Christmas Comes Early for This Mom with Ovarian Cancer
The holidays are a special time of the year to be with family and to give back to the community. The winter season encompasses many holidays and traditions, and can therefore be a time of year where people from all backgrounds cherish loved ones and take time to reflect.But the holiday season can...
- What Causes Bladder Cancer?
What Causes Bladder Cancer?Bladder cancer a common type of cancer that usually begins in the cells lining your bladder, which is also referred to as the transitional epithelium. Just as the other types of cancer, bladder cancer develops into a life-threatening condition. However, 50% of its cases...
- Ovarian Cancer: What You Should Know About Chemotherapy
There’s no better way of putting it: Cancer sucks. The chemotherapy that people take to treat their cancers often ends up making them feel more miserable than the cancer itself was doing before treatment started. People often walk out of chemotherapy feeling broken down, miserable, and sick to...
Nearby Providers
- Dr. Stephen W Louie MD228 Harrison Ave Boston MA 02111
- Dr. Kathy Puyana Theall MD800 Washington St # 245 Boston MA 02111
- Dr. Preethi John MD800 Washington St Boston MA 02111
- Dr. Robert E Martell MD800 Washington St Boston MA 02111
- Dr. Susan J Kim MD800 Washington St Boston MA 02111
- Dr. Hedy P Smith M.D.750 Washington St Boston MA 02111